SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950170-22-017434
Filing Date
2022-08-15
Accepted
2022-08-15 17:45:23
Documents
14

Document Format Files

Seq Description Document Type Size
1 424B3 cmra-q2-2022_424b3.htm 424B3 2835478
2 EX-2.1 cmra-ex2_1.htm EX-2.1 1240357
3 EX-3.1 cmra-ex3_1.htm EX-3.1 72946
4 EX-3.3 cmra-ex3_3.htm EX-3.3 175618
5 EX-4.4 cmra-ex4_4.htm EX-4.4 83927
6 EX-10.1 cmra-ex10_1.htm EX-10.1 133185
7 EX-10.2 cmra-ex10_2.htm EX-10.2 94800
8 EX-10.3 cmra-ex10_3.htm EX-10.3 106409
9 EX-10.12 cmra-ex10_12.htm EX-10.12 67284
10 EX-10.14 cmra-ex10_14.htm EX-10.14 69786
11 EX-31.1 cmra-ex31_1.htm EX-31.1 25783
12 EX-31.2 cmra-ex31_2.htm EX-31.2 25824
13 EX-32.1 cmra-ex32_1.htm EX-32.1 16152
14 EX-32.2 cmra-ex32_2.htm EX-32.2 16392
  Complete submission text file 0000950170-22-017434.txt   4964904
Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801
Business Address 12 GILL STREET SUITE 4650 WOBURN MA 01801 617.871.2101 EXT 313
Comera Life Sciences Holdings, Inc. (Filer) CIK: 0001907685 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-264686 | Film No.: 221167094
SIC: 2834 Pharmaceutical Preparations